Spread of SARS-CoV-2 in a SIS model with vaccination and breakthrough infection
Although previous infection and vaccination provide protection against SARS-CoV-2 infection, both reinfection and breakthrough infection are possible events whose occurrence would increase with time after first exposure to the antigen and with the emergence of new variants of the virus. Periodic vaccination could counteract this decline in protection. In the present work, our aim was to develop and explore a model of SARS-CoV-2 spread with vaccination, reinfection and breakthrough infection. A modified deterministic SIS (Susceptible-Infected-Susceptible) model represented by a system of differential equations was designed. As in any SIS model, the population was divided into susceptible and infected individuals. But in our design, susceptible individuals were, in turn, grouped into three consecutive categories whose susceptibility increases with time after infection or vaccination. The model was studied by means of computer simulations, which were analysed qualitatively. The results obtained show that the prevalence, after oscillating between peaks and valleys, reaches a plateau phase. Moreover, as might be expected, the magnitude of the peaks and plateaus increases as the infection rate rises, the vaccination rate decreases and the rate of decay of protection conferred by vaccination or previous infection increases. Therefore, the present study suggests that, at least under certain conditions, the spread of SARS-CoV-2, although it could experience fluctuations, would finally evolve into an endemic form, with a more or less stable prevalence that would depend on the levels of infection and vaccination, and on the kinetics of post-infection and post-vaccination protection. However, it should be kept in mind that our development is a theoretical scheme with many limitations. For this reason, its predictions should be considered with great care.
Code (0)
등록된 구현이 없습니다.
Similar Papers 제목 키워드 기반
Robust models of SARS-CoV-2 heterogeneity and control
In light of the continuing emergence of new SARS-CoV-2 variants and vaccines, we create a simulation framework for exploring possible infection trajectories under various scenarios. The situations of primary interest inv…
Vaccination shapes evolutionary trajectories of SARS-CoV-2
The large-scale evolution of the SARS-CoV-2 virus has been marked by rapid turnover of genetic clades. New variants show intrinsic changes, notably increased transmissibility, as well as antigenic changes that reduce the…
Theoretical Analysis of SIRVVD Model to Provide Insight on the Target Rate of COVID-19/SARS-CoV-2 Vaccination in Japan
The effectiveness of the first and second dose vaccinations are different for COVID-19; therefore, a susceptible-infected-recovered-vaccination1-vaccination2-death (SIRVVD) model that can represent the states of the firs…
Modelling the impact of vaccination on the COVID-19 pandemic in African countries
The rapid development of vaccines to combat the spread of COVID-19 disease caused by the SARS-CoV-2 virus is a great scientific achievement. Before the development of the COVID-19 vaccines, most studies capitalized on th…
Vaccine efficacy and SARS CoV 2 control in California and USA during the session 2020 2026: A modeling study
Besides maintaining health precautions, vaccination has been the only prevention from SARS-CoV-2, though no clinically proved 100% effective vaccine has been developed till date. At this stage, to withhold the debris of …